MedAdvisor (ASX:MDR) signs 2-year agreement with Sigma Healthcare (ASX:SIG)

Company News

by Rachael Jones

MedAdvisor (ASX:MDR), Australia’s leading digital medication management company, has signed a new 2-year agreement with pharmacy retail group, Sigma Healthcare (ASX:SIG).

Sigma has a network of over 600 retail pharmacy franchise partners including Amcal, DDS, Guardian, PharmaSave, WholeLife and Chemist King pharmacy brands.

The total revenue contribution from the Sigma network of brands under this agreement will increase and is expected to exceed $1 million per year.

Shares in MedAdvisor (ASX:MDR) are trading 8.2 per cent higher to 5 cents.


Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.